MCH ADVISORY RESEARCH
Materials

Specialty Chemicals

13 companies under coverage.

Coverage

Specialty Chemicals


Equity Research

Westlake Chemical Corporation (WLK)

HOLD. 12-month probability-weighted target $78 (+2% vs spot). Gross Margin explains 64% of Monte Carlo outcome variance.

WLKEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Solstice Advanced Materials, Inc (SOLS)

HOLD. 12-month probability-weighted target $57 (+3% vs spot). Gross Margin explains 57% of Monte Carlo outcome variance.

SOLSEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Sherwin-Williams Co (SHW)

HOLD. 12-month probability-weighted target $336 (-3% vs spot). Gross Margin explains 51% of Monte Carlo outcome variance.

SHWEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

RPM International Inc (RPM)

HOLD. 12-month probability-weighted target $103 (-3% vs spot). Gross Margin explains 62% of Monte Carlo outcome variance.

RPMEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

PPG Industries Inc (PPG)

HOLD. 12-month probability-weighted target $118 (+4% vs spot). Gross Margin explains 56% of Monte Carlo outcome variance.

PPGEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

NewMarket Corporation (NEU)

SELL. 12-month probability-weighted target $796 (-15% vs spot). Gross Margin explains 53% of Monte Carlo outcome variance.

NEUEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

LyondellBasell Industries NV (LYB)

SELL. 12-month probability-weighted target $58 (-10% vs spot). Gross Margin explains 51% of Monte Carlo outcome variance.

LYBEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

International Flavors & Fragrances Inc (IFF)

SELL. 12-month probability-weighted target $75 (-12% vs spot). Gross Margin explains 57% of Monte Carlo outcome variance.

IFFEquity ResearchMonte Carlo
25 August 2026Rating: SELL
Equity Research

Ecolab Inc (ECL)

HOLD. 12-month probability-weighted target $277 (-3% vs spot). P/E Multiple explains 53% of Monte Carlo outcome variance.

ECLEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Dupont De Nemours Inc (DD)

HOLD. 12-month probability-weighted target $135 (-1% vs spot). P/E Multiple explains 52% of Monte Carlo outcome variance.

DDEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Axalta Coating Systems Ltd (AXTA)

HOLD. 12-month probability-weighted target $36 (+1% vs spot). Gross Margin explains 56% of Monte Carlo outcome variance.

AXTAEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Avient Corp (AVNT)

HOLD. 12-month probability-weighted target $42 (-5% vs spot). Gross Margin explains 67% of Monte Carlo outcome variance.

AVNTEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Albemarle Corp (ALB)

HOLD. 12-month probability-weighted target $141 (-1% vs spot). P/E Multiple explains 69% of Monte Carlo outcome variance.

ALBEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
MCH ADVISORY SERVICES · All research · Not investment advicemchadvisoryservices.com ↗ · Research Standard v4 (decision-level) · Research OS ros-1.19.0 · US-listed · UK English